This study is comparing a regimen of Docetaxel and Ramucirumab with or without Cemiplimab for participants with recurrent Non-Small Cell Lung Cancer, previously treated with platinum-basesd chemotherapy and immunotherapy.
Contact phone
(517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Non-Small Cell Lung
Webform